NTLA EPS Estimates
Intellia Therapeutics, Inc.
$11.29
-$0.14(-1.24%)
51
Overall
60
Value
54
Tech
39
Quality
Market Cap
$1.60B
Volume
427.15K
52W Range
$7.95 - $28.25
Target Price
$22.33
NTLA EPS estimates: the consensus estimate for Intellia Therapeutics, Inc.'s current fiscal year is -$3.21 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NTLA EPS Estimates
- EPS estimate, current quarter
- $-0.82
- EPS estimate, next quarter
- $-0.78
- EPS estimate, current year
- $-3.21
- EPS estimate, next year
- $-2.32
- EPS growth, 3-year
- +14.80%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.81 |
| 2024 | $-5.25 |
| 2023 | $-5.42 |
| 2022 | $-6.16 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $11.29 | -1.2% | 427.15K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW